Therefore, the C-terminal ROS1 protein level could only be elevated by the strong promoter activity of genes such as SLC34A2 or CD74 in ROS1 fusion–positive lung cancer cells, which suggests that the ROS1 IHC test is a reliable diagnostic test for the detection of patients with lung cancer who have ROS1 fusion. Here, SLC34A2 is linked to lung carcinoma.